Is it possible they are trying to do the insto’s a favor? Everyone has been burnt by this biotech which makes it difficult to raise funds. By letting the insto’s in ahead of results there’s a chance they can recoup some of their accumulated losses and remove some of the smell around Immutep with long suffering sh’s
That’s just pure speculation on my part, trying to put some sort of positive spin on it.
At least the co is moving forward into a ph3. If it works out, even a modest improvement could be very lucrative. The safety profile, low cost of goods and ease of administration mean potentially widespread use in many settings. That’s the pot at the end of rainbow. And at least there is a stated timeline now, 2027. Will it be Boom or Bust ?
IMM Price at posting:
41.0¢ Sentiment: None Disclosure: Not Held
(20min delay)